- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 03.11. | PharmaDrug To Buy 40% Stake in Canurta, Expanding Botanical Therapeutics Portfolio | 2 | pulse2.com | ||
| 31.10. | Pharmadrug Inc (2): Pharmadrug arranges $445,686 debt restructuring | 1 | Stockwatch | ||
| 31.10. | PharmaDrug announces debt restructuring | 2 | Seeking Alpha | ||
| PHARMADRUG Aktie jetzt für 0€ handeln | |||||
| 31.10. | PharmaDrug Inc.: PharmaDrug Announces Debt Restructuring | 220 | Newsfile | Toronto, Ontario--(Newsfile Corp. - October 31, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development... ► Artikel lesen | |
| 30.10. | Pharmadrug Inc (2): Pharmadrug firms up deal to acquire 40% of Canurta | 3 | Stockwatch | ||
| 30.10. | PharmaDrug signs definitive agreement to acquire equity interest in Canurta | 7 | Seeking Alpha | ||
| 30.10. | PharmaDrug Inc.: PharmaDrug Signs Definitive Agreement to Acquire Equity Interest in Canurta Inc | 160 | Newsfile | Toronto, Ontario--(Newsfile Corp. - October 30, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development... ► Artikel lesen | |
| 30.07. | Pharmadrug Inc (2): Pharmadrug enters LOI to acquire 40% of Canurta | 3 | Stockwatch | ||
| 30.07. | Pharmadrug Inc (2): Pharmadrug corrects July 30 NR | 1 | Stockwatch | ||
| 30.07. | Pharmadrug Inc (2): Pharmadrug resumes at 9:30 a.m. PT | 1 | Stockwatch | ||
| 30.07. | PharmaDrug Inc.: PharmaDrug Signs LOI to Acquire Equity Interest in Canurta Inc. | 635 | Newsfile | Toronto, Ontario--(Newsfile Corp. - July 30, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development... ► Artikel lesen | |
| 30.07. | Pharmadrug Inc (2): Pharmadrug halted at 6:33 a.m. PT | 2 | Stockwatch | ||
| 17.06. | Pharmadrug Inc (2): Pharmadrug director, CEO Steen resigns | 3 | Stockwatch | ||
| 16.06. | PharmaDrug CEO Rob Steen steps down | 3 | Seeking Alpha | ||
| 16.06. | PharmaDrug Inc.: PharmaDrug Announces Resignation of Rob Steen as CEO and From Board of Directors | 408 | Newsfile | Toronto, Ontario--(Newsfile Corp. - June 16, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development... ► Artikel lesen | |
| 06.06. | Pharmadrug Inc (2): Pharmadrug puts itself on the block | 3 | Stockwatch | ||
| 06.06. | PharmaDrug Inc.: PharmaDrug Announces Strategic Review Process Intended to Maximize Shareholder Value | 330 | Newsfile | Toronto, Ontario--(Newsfile Corp. - June 6, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development... ► Artikel lesen |
17 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 3,710 | -0,13 % | Aurora Cannabis Inc.: Aurora Cannabis Announces Fiscal 2026 Second Quarter Results | Expands YoY Global Medical Cannabis Net Revenue 1 by 15% to Record $70.5 million
Increases International Medical Cannabis Net Revenue 1 by 22% to... ► Artikel lesen | |
| CANOPY GROWTH | 0,902 | -1,64 % | Cannabis-Aktien im Fokus: Canopy Growth und Bioxyne - alles dreht sich um strategische Umsetzung! | ||
| HALO COLLECTIVE | 0,010 | 0,00 % | Waters Corporation Buys Halo Labs | WASHINGTON (dpa-AFX) - Waters Corporation (WAT), an analytical instruments and software firm, said on Wednesday that it has acquired Halo Labs, a company focused on specialized imaging technologies... ► Artikel lesen | |
| TILRAY BRANDS | 0,915 | -1,06 % | Tilray Brands, Inc.: Tilray Brands Condemns Misguided Prohibitionist Measures and Champions Responsible Hemp Regulations that Keep Consumers Safe and Businesses Thriving | NEW YORK, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray Brands" or "Tilray") (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of... ► Artikel lesen | |
| INNOCAN PHARMA | 9,650 | -0,52 % | InnoCan Pharma: Big News noch vor dem Nasdaq-IPO? | ||
| TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | TAAT Global Alternatives Inc (2): TAAT Global CEO Saxon resigns | ||
| DERMAPHARM | 34,500 | +0,29 % | Dermapharm bestätigt Jahresziele - Umbau belastet Umsatz | GRÜNWALD (dpa-AFX) - Der Umbau des Parallelimportegeschäfts bremst den Pharmahersteller Dermapharm . Obwohl dieses Geschäft mit Markenarzneien weiter florierte, ging der Konzernumsatz in den ersten... ► Artikel lesen | |
| CRONOS GROUP | 2,076 | -1,70 % | Cronos Group Inc.: Cronos Group Reports 2025 Second Quarter Results | Net revenue in Q2 2025 increased by 21% year-over-year PEACE NATURALS® retained its position as the number one cannabis brand in Israel1 Highest-ever international and Israel revenue, fueled by strong... ► Artikel lesen | |
| VIATRIS | 9,164 | -0,72 % | Viatris (VTRS) Jumps 10% on Reaffirmed Growth Targets | ||
| SYNBIOTIC | 2,120 | -0,70 % | EQS-News: SYNBIOTIC SE: SYNBIOTIC begrüßt Antrag der Grünen zum Nutzhanfliberalisierungsgesetz und fordert Sachlichkeit in der Medizinalcannabis-Debatte | EQS-News: SYNBIOTIC SE
/ Schlagwort(e): Stellungnahme
SYNBIOTIC begrüßt Antrag der Grünen zum Nutzhanfliberalisierungsgesetz und fordert Sachlichkeit in der Medizinalcannabis-Debatte... ► Artikel lesen | |
| DIGICANN VENTURES | 0,004 | 0,00 % | Digicann Ventures Inc.: Digicann Ventures to Resume Trading on the Canadian Securities Exchange | Vancouver, British Columbia--(Newsfile Corp. - November 10, 2025) - Digicann Ventures Inc. (CSE: DCNN.X) ("Digicann" or the "Company"), a company focused on opportunities within and outside of the... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 1,330 | +2,31 % | ORGANIGRAM GLOBAL INC. - 6-K, Report of foreign issuer | ||
| GREEN THUMB INDUSTRIES | 5,085 | +1,74 % | Green Thumb Industries Reports Third Quarter 2025 Results | CHICAGO and VANCOUVER, British Columbia, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. ("Green Thumb" or the "Company") (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer... ► Artikel lesen | |
| SNDL | 1,419 | -2,14 % | SNDL Inc.: SNDL Announces 2025 Annual and Special Meeting Results | EDMONTON, AB, July 31, 2025 /PRNewswire/ - SNDL Inc. (NASDAQ: SNDL) (CSE: SNDL) ("SNDL" or the "Company") is pleased to announce the resolutions put to holders... ► Artikel lesen | |
| CRESCO LABS | 0,838 | +2,57 % | Cresco Labs Launches Flagship Flower Brand in Germany | New market entry pilots three signature Cresco offerings /Germany/EU Regulatory Notice: This communication is not intended for patients or the general public in Germany or the EU and does not... ► Artikel lesen |
PHARMADRUG INC gehört der Branche Pharma an. Die relative Kursveränderung beträgt aktuell -93,75 % bei einem Aktienkurs von 0,001 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PHARMADRUG INC finden Sie auf Wallstreet Online.